Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Apr 4, 2012 at 1:28 PM EDT

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment…

Jon C. Ogg | Apr 3, 2012 at 1:10 PM EDT

Pacific Biosciences Files to Raise Capital (PACB)

Pacific Biosciences of California, Inc. (NASDAQ: PACB) has just filed paperwork with the Securities and Exchange Commission to raise up…

Jon C. Ogg | Apr 3, 2012 at 8:24 AM EDT

Astex Gets on the Map (ASTX)

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) is the NASDAQ pre-market leader this morning on news that its subcutaneous SGI-110 interim phase…

Jon C. Ogg | Apr 2, 2012 at 4:09 PM EDT

Stemline Therapeutics Files for IPO (STML)

Stemline Therapeutics, Inc. has just filed its paperwork with the Securities and Exchange Commission that will allow it to conduct an…

Paul Ausick | Apr 2, 2012 at 12:23 PM EDT

Theravance Jumps on Glaxo Investment (THRX, GSK)

Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc…

Jon C. Ogg | Apr 2, 2012 at 10:03 AM EDT

Merger Watchdogs Asleep in Medco-Express PBM Merger? (MHS, ESRX)

Isn’t the current administration’s watch-dog policy supposed to police mergers and acquisitions in regards to competition and pricing power? Many…

Paul Ausick | Apr 2, 2012 at 9:43 AM EDT

Express Scripts, Medco Merger Completed (ESRX, CVS)

The $29.1 billion merger between Express Scripts Inc. (NASDAQ: ESRX) and Medco Health Solutions Inc. has been cleared by the…

Paul Ausick | Apr 2, 2012 at 7:54 AM EDT

Keryx Drug Fails Test, Shares Plunge (KERX)

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) this morning announced that its colorectal cancer treatment did no better than placebo in a…

Jon C. Ogg | Mar 29, 2012 at 10:41 AM EDT

Neostem Pounds Holders In Capital Raise (NBS)

If there is one sector you can count on to raise capital either after opportunistic share price gains or at…

Paul Ausick | Mar 29, 2012 at 10:14 AM EDT

Oracle Buys Drug Trial Software Firm (ORCL)

Oracle Corp. (NASDAQ: ORCL) has announced that it will acquire ClearTrial, a maker of cloud-based Clinical Trial Operations applications for…

Jon C. Ogg | Mar 29, 2012 at 9:20 AM EDT

Potential Deathblow for Chelsea (CHTP)

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning. News hit that the FDA has now rejected…

Jon C. Ogg | Mar 29, 2012 at 7:11 AM EDT

Globus Files For IPO, Profitable Medical Devices (GMED)

Globus Medical, Inc. is the latest of the companies filing with the Securities and Exchange Commission to come public via…

Paul Ausick | Mar 28, 2012 at 10:10 AM EDT

Vermillion Scores Patent on Cancer Test (VRML)

Shares of diagnostics company Vermillion Inc. (NASDAQ: VRML) have jumped more than 20% this morning following the company’s announcement of…

Jon C. Ogg | Mar 28, 2012 at 9:52 AM EDT

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). …

Paul Ausick | Mar 27, 2012 at 9:41 AM EDT

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Development stage drug maker Targacept Inc. (NASDAQ: TRGT) is having its troubles these days. Earlier this month the company said…

1 … 320 321 322 323 324 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Pacific Biosciences Files to Raise Capital (PACB)

Astex Gets on the Map (ASTX)

Stemline Therapeutics Files for IPO (STML)

Theravance Jumps on Glaxo Investment (THRX, GSK)

Merger Watchdogs Asleep in Medco-Express PBM Merger? (MHS, ESRX)

Express Scripts, Medco Merger Completed (ESRX, CVS)

Keryx Drug Fails Test, Shares Plunge (KERX)

Neostem Pounds Holders In Capital Raise (NBS)

Oracle Buys Drug Trial Software Firm (ORCL)

Potential Deathblow for Chelsea (CHTP)

Globus Files For IPO, Profitable Medical Devices (GMED)

Vermillion Scores Patent on Cancer Test (VRML)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Pacific Biosciences Files to Raise Capital (PACB)

Astex Gets on the Map (ASTX)

Stemline Therapeutics Files for IPO (STML)

Theravance Jumps on Glaxo Investment (THRX, GSK)

Merger Watchdogs Asleep in Medco-Express PBM Merger? (MHS, ESRX)

Express Scripts, Medco Merger Completed (ESRX, CVS)

Keryx Drug Fails Test, Shares Plunge (KERX)

Neostem Pounds Holders In Capital Raise (NBS)

Oracle Buys Drug Trial Software Firm (ORCL)

Potential Deathblow for Chelsea (CHTP)

Globus Files For IPO, Profitable Medical Devices (GMED)

Vermillion Scores Patent on Cancer Test (VRML)

The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500